Guided Therapeutics Inc financial data

Symbol
GTHP on OTC
Industry
Electromedical & Electrotherapeutic Apparatus
Location
5835 Peachtree Corners East, Suite B, Peachtree Corners, GA
State of incorporation
DE
Fiscal year end
December 31
Former names
SPECTRX INC (to 2/28/2008)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 19.4 % -52.4%
Quick Ratio 10.9 % -17%
Debt-to-equity -129 % +21.5%
Return On Assets -180 % -13.3%
Operating Margin -30.1K % -754%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78M shares +40.2%
Common Stock, Shares, Outstanding 65.1K shares
Entity Public Float 3.72M USD -67.6%
Common Stock, Value, Issued 3.45M USD +0.32%
Weighted Average Number of Shares Outstanding, Basic 57K shares +10.8%
Weighted Average Number of Shares Outstanding, Diluted 57.3K shares +12.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 7K USD -92.9%
Research and Development Expense 526K USD +131%
Selling and Marketing Expense 287K USD +7.09%
General and Administrative Expense 1.3M USD -56.7%
Operating Income (Loss) -2.11M USD +39%
Nonoperating Income (Expense) -309K USD -866%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -2.42M USD +30.7%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -2.42M USD +30.7%
Earnings Per Share, Basic -0.05 USD/shares +28.6%
Earnings Per Share, Diluted -0.05 USD/shares +28.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 731K USD -72.9%
Accounts Receivable, after Allowance for Credit Loss, Current 3K USD -57.1%
Inventory, Net 633K USD +0.16%
Other Assets, Current 173K USD +6.14%
Assets, Current 1.2M USD -14.1%
Property, Plant and Equipment, Net 23K USD -28.1%
Operating Lease, Right-of-Use Asset 141K USD -37.9%
Other Assets, Noncurrent 17K USD 0%
Assets 1.38M USD -17.4%
Accounts Payable, Current 2.09M USD +5.17%
Accrued Liabilities, Current 1.01M USD -5.34%
Liabilities, Current 6.16M USD +28%
Operating Lease, Liability, Noncurrent 49K USD -68.4%
Liabilities 6.27M USD +14.5%
Retained Earnings (Accumulated Deficit) -154M USD -1.72%
Stockholders' Equity Attributable to Parent -4.89M USD -28.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -4.9M USD
Liabilities and Equity 1.38M USD -17.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -100K USD +80%
Net Cash Provided by (Used in) Financing Activities -46K USD -300%
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 65.1K shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 388K USD -34.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 12K USD -74.5%
Deferred Tax Assets, Valuation Allowance 17.6M USD -2.19%
Deferred Tax Assets, Gross 17.6M USD -2.19%
Operating Lease, Liability 155K USD -37%
Depreciation 2K USD 0%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 168K USD -40.6%
Property, Plant and Equipment, Gross 1.61M USD 0%
Operating Lease, Liability, Current 106K USD +16.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 50K USD +78.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 50K USD -56.5%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13K USD -64.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 50K USD -56.5%
Deferred Tax Assets, Operating Loss Carryforwards 16M USD -2.63%
Lessee, Operating Lease, Liability, to be Paid, Year Four 118K USD 0%
Additional Paid in Capital 143M USD +1.08%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 14.8K USD -86.1%
Interest Expense 381K USD +37.1%